Table of Contents
(Source: Progress in Cardiovascular Diseases)
Source: Progress in Cardiovascular Diseases - June 1, 2017 Category: Cardiology Source Type: research

List of Recent Issues
(Source: Progress in Cardiovascular Diseases)
Source: Progress in Cardiovascular Diseases - June 1, 2017 Category: Cardiology Source Type: research

Editorial Board
(Source: Progress in Cardiovascular Diseases)
Source: Progress in Cardiovascular Diseases - June 1, 2017 Category: Cardiology Source Type: research

Public Park Spaces as a Platform to Promote Healthy Living: Introducing a HealthPark Concept
The concept of Healthy Living (HL) as a primary medical intervention continues to gain traction, and rightfully so. Being physically active, consuming a nutritious diet, not smoking and maintaining an appropriate body weight constitute the HL polypill, the foundation of HL medicine (HLM). Daily use of the HL polypill, working toward optimal dosages, portends profound health benefits, substantially reducing the risk of chronic disease [i.e., cardiovascular disease (CVD), pulmonary disease, metabolic syndromes, certain cancers, etc.] and associated adverse health consequences. (Source: Progress in Cardiovascular Diseases)
Source: Progress in Cardiovascular Diseases - May 30, 2017 Category: Cardiology Authors: Ross Arena, Samantha Bond, Robert O'Neil, Deepika R. Laddu, Andrew P Hills, Carl J. Lavie, Amy McNeil Tags: None. Source Type: research

Heart Failure with Myocardial Recovery - The Patient Whose Heart Failure Has Improved: What Next?
In an important number of heart failure (HF) patients substantial or complete myocardial recovery occurs. In the strictest sense, myocardial recovery is a return to both normal structure and function of the heart. HF patients with myocardial recovery or recovered ejection fraction (EF; HFrecEF) are a distinct population of HF patients with different underlying etiologies, demographics, comorbidities, response to therapies and outcomes compared to HF patients with persistent reduced (HFrEF) or preserved ejection fraction (HFpEF). (Source: Progress in Cardiovascular Diseases)
Source: Progress in Cardiovascular Diseases - May 24, 2017 Category: Cardiology Authors: Petra Nijst, Pieter Martens, Wilfried Mullens Source Type: research

Heart failure with Myocardial Recovery- The Patient Whose Heart Failure Has Improved: What Next?
In an important number of heart failure (HF) patients substantial or complete myocardial recovery occurs. In the strictest sense, myocardial recovery is a return to both normal structure and function of the heart. HF patients with myocardial recovery or recovered ejection fraction (EF; HFrecEF) are a distinct population of HF patients with different underlying etiologies, demographics, comorbidities, response to therapies and outcomes compared to HF patients with persistent reduced (HFrEF) or preserved ejection fraction (HFpEF). (Source: Progress in Cardiovascular Diseases)
Source: Progress in Cardiovascular Diseases - May 24, 2017 Category: Cardiology Authors: Petra Nijst, Pieter Martens, Wilfried Mullens Source Type: research

Imaging the cervical vasculature
There are many ways to image the cervical vasculature. Each of the imaging techniques will be discussed in detail, including the method of performance, the quality of the images, the advantages and disadvantages compared to other techniques, and the potential complications. The disease entities will be discussed and illustrated with pathologically and clinically proven case material. (Source: Progress in Cardiovascular Diseases)
Source: Progress in Cardiovascular Diseases - May 22, 2017 Category: Cardiology Authors: Richard E. Latchaw, Sheri L. Albers Source Type: research

Medical Management of Asymptomatic Carotid Artery Stenosis
Carotid artery atherosclerosis is a major risk factor for both stroke and cardiovascular disease. Appropriate management of asymptomatic patients with carotid artery stenosis (CAS) remains unclear. Although several randomized clinical trials support revascularization in asymptomatic patients with severe CAS to reduce stroke risk, the participants in these trials did not receive optimal medical therapy (OMT) by today's standards. For many individuals, medical therapy may provide excellent risk reduction without the periprocedural risk of endarterectomy or stenting. (Source: Progress in Cardiovascular Diseases)
Source: Progress in Cardiovascular Diseases - May 21, 2017 Category: Cardiology Authors: Aaron W. Aday, Joshua A. Beckman Source Type: research

The Interaction of Cardiorespiratory Fitness with Obesity and the Obesity Paradox in Cardiovascular Disease
Overweight and obesity are well-established risk factors for most cardiovascular diseases (CVD), including coronary heart disease (CHD), heart failure (HF), and atrial fibrillation. Despite the strong link between excess adiposity and risk of CVD, growing evidence has demonstrated an obesity paradox in patients with CVD. This phenomenon is characterized by a better prognosis in overweight and mildly obese CVD patients than their leaner counterparts. Moreover, the worst outcomes are often incurred by underweight CVD patients, followed by those of normal weight or severely obese. (Source: Progress in Cardiovascular Diseases)
Source: Progress in Cardiovascular Diseases - May 12, 2017 Category: Cardiology Authors: Ahmet Af şin Oktay, Carl J. Lavie, Peter F. Kokkinos, Parham Parto, Ambarish Pandey, Hector O. Ventura Source Type: research

Exercise Training in Athletes with Heart Disease
Exercise events and sport participation have increased over recent decades. The average age of sports participants has also increased with a potential parallel increase in the number of exercise participants with both occult and diagnosed cardiovascular disease (CVD). Habitual physical activity and exercise training reduce atherosclerotic CVD (ASCVD) risk in a curvilinear fashion by affecting multiple ASCVD risk factors. Nonetheless, exercise also increases the risk of sudden cardiac death in both young and adult individuals with occult CVD making it important to balance the risks and benefits of exercise and exercise trai...
Source: Progress in Cardiovascular Diseases - May 12, 2017 Category: Cardiology Authors: Antonio B. Fernandez, Paul D. Thompson Source Type: research

The Role for Cardiologists in Stroke Intervention
Even though cardiovascular disease (CVD) is still the leading cause of death in the United States, stroke is the second leading of global cause of death behind CVD . In the 21st Century, less than 40% of overall stroke patients are discharged to home and almost 25% of Medicare beneficiaries do not survive 90days. In spite of the fact that tissue plasminogen activator (TPA) has been approved for stroke care for 20years, only .75% of annual strokes are actually treated with intravenous (IV) TPA. Similar to how interventional cardiologists evolved from IV to catheter mechanical treatment for acute myocardial infarctions (AMI)...
Source: Progress in Cardiovascular Diseases - May 11, 2017 Category: Cardiology Authors: Richard R. Heuser Source Type: research

Late In-hospital Management of Patients Hospitalized with Acute Heart Failure
Acute Heart Failure (AHF) hospitalization presents a significant financial burden and portends a poor prognosis following discharge. As such, there has been significant emphasis on the late inpatient management of patients hospitalized with AHF to ensure successful transition to the outpatient setting and to reduce overall readmission and mortality rates. Thorough discharge planning and a multidisciplinary team approach are essential and as outlined in this review should focus on four key elements: the assessment of patients' readiness for discharge, optimization of goal directed medical therapy and appropriate device ther...
Source: Progress in Cardiovascular Diseases - May 10, 2017 Category: Cardiology Authors: Nicole B Cyrille, Snehal R. Patel Source Type: research

Palliative Care in Heart Failure: What Triggers Specialist Consultation?
Heart failure (HF) continues to cause substantial death and suffering despite the availability of numerous medical, surgical, and technological therapeutic advancements. As a patient-centered holistic discipline focused on improving quality of life and decreasing anguish, palliative care (PC) has a crucial role in the care of HF patients that has been acknowledged by multiple international guidelines. PC can be provided by all members of the HF care team, including but not limited to practitioners with specialty PC training. (Source: Progress in Cardiovascular Diseases)
Source: Progress in Cardiovascular Diseases - May 5, 2017 Category: Cardiology Authors: Mitchell A. Psotka, Kanako Y. McKee, Albert Y. Liu, Giovanni Elia, Teresa De Marco Source Type: research

Asymptomatic Carotid Artery Stenosis: Revascularization
In patients with carotid stenosis, the most common cause of stroke is atheroembolization, and the risk is strongly related to stenosis severity and symptomatic status (stroke or transient ischemic attack within 6months). Carotid revascularization by carotid endarterectomy (CEA) or carotid artery stenting (CAS) result in plaque “passivation” by lumen enlargement, plaque removal, or plaque coverage with subsequent endothelialization. While there is considerable circumstantial evidence linking a decrease in the risk of stroke to the use of “optimal medical therapy (OMT)”, the components of OMT have not been defined, a...
Source: Progress in Cardiovascular Diseases - May 3, 2017 Category: Cardiology Authors: Robert D. Safian Source Type: research

Stroke Treatment and Prevention
Stroke is the leading cause of permanent disability in the United States (US). Each year approximately 795,000 people suffer from a stroke in the US, now being the number five cause of death behind heart disease, cancer, chronic lower respiratory disease, and accidents. In fact 1 in 20 people die from a stroke.1 In 2013 there were 6.5 million stroke deaths worldwide. On a global basis, stroke is the number two cause of death behind ischemic heart disease.2 The vast majority of strokes are ischemic (87%). (Source: Progress in Cardiovascular Diseases)
Source: Progress in Cardiovascular Diseases - May 1, 2017 Category: Cardiology Authors: Rajan A.G. Patel, Christopher J. White Tags: Editorial Source Type: research